effects oncogenic mutations smoothened patched can reversed cyclopamine 
basal cell carcinoma medulloblastoma rhabdomyosarcoma human tumours associated mutations activate proto-oncogene smoothened smo inactivate tumour suppressor patched ptch smoothened patched mediate cellular response hedgehog hh secreted protein signal oncogenic mutations affecting proteins cause excess activity hh response pathway show plant-derived teratogen cyclopamine inhibits hh response potential mechanism-based therapeutic agent treatment tumours show cyclopamine synthetic derivatives improved potency block activation hh response pathway abnormal cell growth associated types oncogenic mutation results also indicate cyclopamine may act influencing balance active inactive forms smoothened 
